Cristina Leon

Cristina Leon

M&S Decisions, Moscow, Moskva, Russia
+2
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
Cristina LeonCristina Leon
Cristina Leon
ATAlexey Tokarev
Alexey Tokarev
ABAnass Bouchnita
Anass Bouchnita
Vitaly VolpertVitaly Volpert
Vitaly Volpert
In this work, we develop mathematical models of the immune response to respiratory viral infection, taking into account some particular properties of the SARS-CoV infections, cytokine storm and vaccination. Each model consists of a system of ordinary differential equations that describe the interactions of the virus, epithelial cells, immune cells, cytokines, and antibodies. Conventional analysis of the existence and stability of stationary points is completed by numerical simulations in order to study the dynamics of solutions. The behavior of the solutions is characterized by large peaks of virus concentration specific to acute respiratory viral infections. At the first stage, we study the innate immune response based on the protective properties of interferon secreted by virus-infected cells. Viral infection down-regulates interferon production. This competition can lead to the bistability of the system with different regimes of infection progression with high or low intensity. After that, we introduce the adaptive immune response with antigen-specific T- and B-lymphocytes. The resulting model shows how the incubation period and the maximal viral load depend on the initial viral load and the parameters of the immune response. In particular, an increase in the initial viral load leads to a shorter incubation period and higher maximal viral load. The model shows that a deficient production of antibodies leads to an increase in the incubation period and even higher maximum viral loads. In order to study the emergence and dynamics of cytokine storm, we consider proinflammatory cytokines produced by cells of the innate immune response. Depending on the parameters of the model, the system can remain in the normal inflammatory state specific for viral infections or, due to positive feedback between inflammation and immune cells, pass to cytokine storm characterized by the excessive production of proinflammatory cytokines. Finally, we study the production of antibodies due to vaccination. We determine the dose–response dependence and the optimal interval of vaccine dose. Assumptions of the model and obtained results correspond to the experimental and clinical data.

19 May 2020 in Mathematics and Mechanics of Complex Systems
Verified
Journal Article
Open access
PDF file
NBNikolai Bessonov
Nikolai Bessonov
GBGennady Bocharov
Gennady Bocharov
Cristina LeonCristina Leon
Cristina Leon
VPVladimir Popov
Vladimir Popov
Vitaly VolpertVitaly Volpert
Vitaly Volpert
Virus density distribution as a function of genotype considered as a continuous variable and of time is studied with a nonlocal reaction-diffusion equation taking into account virus competition for the host cells and its elimination by the immune response and by the genotype-dependent mortality. The existence of virus strains, that is, of positive stable stationary solutions decaying at infinity, is determined by the admissible intervals in the genotype space where the genotype-dependent mortality is less than the virus reproduction rate, and by the immune response under some appropriate assumptions on the immune response function characterizing virus elimination by immune cells. The competition of virus strains is studied, first, without immune response and then with the immune response. In the absence of immune response, the strain dynamics is different in a short time scale where they converge to some intermediate slowly evolving solutions depending on the initial conditions, and in a long time scale where their distribution converges to a stationary solution. Immune response can essentially influence the strain dynamics either stabilizing them or eliminating one of the strains. An antiviral treatment can also influence the competition of virus strains, and it can lead to the emergence of resistant strains, which were absent before the treatment because of the competition with susceptible strains.

11 September 2023 in American Journal of Hypertension
Verified
Journal Article
Closed access
PDF file
TSTatiana Safronova
Tatiana Safronova
AKAnna Kravtsova
Anna Kravtsova
SVSergei Vavilov
Sergei Vavilov
Cristina LeonCristina Leon
Cristina Leon
ABAnna E. Bragina
Anna E. Bragina
VPValery Podzolkov
Valery Podzolkov
BACKGROUND: Cardio-ankle vascular index (CAVI) and its modified version (CAVI0) are promising non-invasive markers of arterial stiffness, extensively evaluated primarily in the Japanese population. In this work, we performed a model-based analysis of the association between different population characteristics and CAVI or CAVI0 values in healthy Russian subjects and propose a tool for calculating the range of reference values for both types of indices. METHODS: The analysis was based on the data from 742 healthy volunteers (mean age 30.4 years; 73.45% men) collected from a multicenter observational study. Basic statistical analysis [analysis of variance, Pearson’s correlation (r), significance tests] and multivariable linear regression were performed in R software (version 4.0.2). Tested covariates included age, sex, BMI, blood pressure, and heart rate (HR). RESULTS: No statistically significant difference between healthy men and women were observed for CAVI and CAVI0. In contrast, both indices were positively associated with age (r = 0.49 and r = 0.43, P < 0.001), however, with no clear distinction between subjects of 20–30 and 30–40 years old. Heart rate and blood pressure were also identified as statistically significant predictors following multiple linear regression modeling, but with marginal clinical significance. Finally, the algorithm for the calculation of the expected ranges of CAVI in healthy population was proposed, for a given age category, HR and pulse pressure (PP) values. CONCLUSIONS: We have evaluated the quantitative association between various population characteristics, CAVI, and CAVI0 values and established a method for estimating the subject-level reference CAVI and CAVI0 measurements.

6 March 2022 in Israel Journal of Mathematics
Verified
Journal Article
Closed access
PDF file
Cristina LeonCristina Leon
Cristina Leon
IKIrina Kutsenko
Irina Kutsenko
Vitaly VolpertVitaly Volpert
Vitaly Volpert

20 December 2024 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Open access
YYYan‐Ou Yang
Yan‐Ou Yang
VSVictor Sokolov
Victor Sokolov
AVAlina Volkova
Alina Volkova
XLXing Liu
Xing Liu
Cristina LeonCristina Leon
Cristina Leon
XCXuejun Chen
Xuejun Chen
Axatilimab, a high‐affinity humanized immunoglobulin G4 monoclonal antibody against colony‐stimulating factor 1 receptor (CSF‐1R), is approved for the treatment of chronic graft‐versus‐host disease (cGVHD), and under investigation for idiopathic pulmonary fibrosis and solid tumors. The population pharmacokinetics (PK) and pharmacodynamics (PD) of axatilimab were characterized in healthy participants and patients with solid tumors or cGVHD using data from four clinical studies with 325 participants, including 278 patients with cGVHD. The model structure reflected the mechanism of action of axatilimab: blocking CSF‐1R signaling with axatilimab reduces the circulating levels of cells in the mononuclear phagocytic cell lineage (including nonclassical monocytic cells (NCMCs) and Kupffer cells), resulting in increases in circulating enzymes owing to reduced clearance by Kupffer cells. The structural model consisted of a two‐compartment axatilimab PK model and turnover PD models for CSF‐1, NCMCs, aspartate transaminase (AST), and creatine phosphokinase (CPK). Axatilimab PK and CSF‐1 equations also included saturable clearance components to reflect the competitive binding of axatilimab and CSF‐1 to CSF‐1R. Covariate search was conducted with the conditional sampling use for the stepwise approach based on correlation tests (COSSAC) approach. Covariate effects on model parameters, steady‐state axatilimab exposure, and NCMC concentrations were assessed. The final population PK/PD model was mathematically described with 6 ordinary differential equations and 39 model parameters. Among the 11 statistically significant covariates, one (body weight) and two (participant population type and baseline CPK) covariates affected axatilimab steady‐state exposure and steady‐state NCMC levels by > 20%, respectively. These results informed the axatilimab dosing strategy in patients with cGVHD.

1 June 2022 in Computer Research and Modeling
Verified
Journal Article
Open access
Cristina LeonCristina Leon
Cristina Leon
ATAlexey A. Tokarev
Alexey A. Tokarev
VVVitaly A Volpert
Vitaly A Volpert